Bicara Therapeutics Statistics
NASDAQ: BCAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.42-0.14 (-0.85%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Bicara Therapeutics by the numbers
Bicara Therapeutics has a market capitalization of $1.09 billion based on 66.17M shares outstanding. With trailing EPS of $-3.08, Bicara Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.3% below its 50-day average and 22.9% below its 200-day average.
Average daily trading volume is 609.70K shares, or about $10.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCAX valuation vs. peer median
| Metric | BCAX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.09B | $1.10B | -1% |
| Avg. volume | 609.70K | 670.67K | -9% |
Peer median across 8 companies: JANX, TRAX, LBRX, AMPH, MNKD, AVLN, HROW, OPK.
Valuation
- Market cap
- $1.09B
- EPS (TTM)
- $-3.08
- Shares outstanding
- 66.17M
Price and trading
- Previous close
- 16.56
- Open
- 16.44
- Day range
- 16.25 – 17.11
- 52-week range
- 13.70 – 30.99
- 52-week change
- -9.63%
- Beta
- —
- Volume
- 915.59K
- Average volume
- 609.70K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 1.09B
- Forward Pe
- -4.67
- Eps
- -3.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 30.99
- Week52 Low
- 13.70
- Avg Volume
- 609.70K
- Shares Outstanding
- 66.17M
- Ma50
- 23.23
- Ma200
- 21.30
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -47.02%
- Pct From52w Low
- 19.85%